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d-ROMs Test Detects Ceruloplasmin, Not Oxidative Stress

To the Editor:
We read with interest the article by Papageorgiou et al (November 2005) 1 reporting that the measurement of oxidative stress levels with a rapid commercially available method (dROMs test; Diacron; Grosseto, Italy) was highly repeatable in the patients studied and may serve as a marker for differentiation between exudates and transudates in clinical practice.
Unfortunately, the basic principle of the d-ROMs test is invalid. In this method, overall oxidative stress is measured indirectly by measuring the level of total hydroperoxides. However, the alchilamine used as a chromogen in this method is also a substrate for the ceruloplasmin (ferroxidase) enzyme, which is abundantly present in serum; the type of buffer used and its pH are more appropriate for ferroxidase activity. This is borne out by the fact that a significant positive correlation between the assay results and ferroxidase activity has been found (r ϭ 0.911; p Ͻ 0.001; n ϭ 100) [ 2 In a study by Calikoglu et al, 3 it was shown that acute-phase reactants, especially ceruloplasmin, have a high sensitivity, specificity, and area under the receiving operator characteristic curve (92%, 85%, and 0.98, respectively) in the discrimination of exudative pleural effusions. These values are very similar to the findings of Papageorgiou et al 1 (96%, 96%, and 0.99, respectively). Moreover, the significance of the ceruloplasmin values between exudates and transudates ( Table 2 in the article by  Calikoglu et al  3 ) were surprisingly similar to the findings of Papageorgiou et al 1 for these two groups. 3 It is apparent that the results published by Papageorgiou et al 1 To the Editor:
We appreciate Dr. Harma's comments regarding our article on oxidative stress levels in pleural effusions as a marker for the differentiation between exudates and transudates. 1 The d-ROMs test (Diacron; Grosseto, Italy) may indeed measure ceruloplasmin oxidase activity besides the total level of hydroperoxides, and this is known from the initial study 2 that has validated the d-ROMs method. However, the contribution of ceruloplasmin oxidase activity to the typical change of absorbance at the 505 nm of the d-ROMs test, although not negligible, is relatively small, especially due to the fact that in the d-ROMs method for the serum the sample is 100-fold diluted. 2 The same probably applies for the pleural fluid samples, as we have used the same dilutions.
The correlation between ceruloplasmin oxidase activity and the d-ROMs test has not been shown in clinical practice. In hemodialyzed patients, for instance, the d-ROMs values are increased, 3 whereas the ceruloplasmin oxidase activity is reduced. 4 Additionally, d-ROMs have been validated in large populations of healthy subjects, alcohol abusers, and in various disease states. Interestingly, d-ROMs are increased in patients undergoing prolonged hyperbaric oxygen treatment and correlate with malondialdehyde levels, another marker of oxidative stress. 5 Therefore, the similarities between the diagnostic performance of d-ROMs and ceruloplasmin for the differentiation between exudative and transudative pleural effusions referred by Harma et al are only speculative, and further research is needed in that direction.
In our study, we used d-ROMs as a marker of overall oxidative stress in the pleural fluid, and we concluded that this method is repeatable and represents an excellent marker for the differentiation of exudates and transudates. We believe that further research is needed for the clarification of the mechanisms of
